AUSTRALIA, Ocotber 8, 2019, (CANNABISNOW) In the decades since the medical marijuana movement began in earnest in the 1970s, cannabis has been anecdotally touted as an effective treatment for a variety of illnesses, including those impacting brain function, such as seizures, anxiety and depression. However, peer-reviewed research into the...
U.S, July 12, 2021 (ANALYTICALCANNABIS) With cannabis cultivation operating underground throughout much of the 20th century, the species lost a significant amount of genetic diversity. Just like with alcohol prohibition during the 1920s, cannabis prohibition served to push THC levels upward to the exclusion of other traits.
UNITED KINGDOM, October 9, 2019, (HEALTH EUROPA) - Zelda Therapeutics Limited has announced a proposed merger of equals with Ilera Therapeutics LLC (Ilera Therapeutics).
Ilera Therapeutics is a privately held medical cannabis and cannabinoid science company based in the United States and, subject to approval from Zelda shareholders and all conditions of sale being met,...
U.S, November 27, 2019 (HEMPGAZETTE) A recent study out of Washington State University indicates inhaled cannabis may reduce the intensity of headaches and migraines.
Led by Carrie Cuttler, a WSU assistant professor of psychology, a research term analyzed information submitted by more than 1,300 patients who used the Strainprint app...
A new study suggests CBD could play a role in fighting antibiotic-resistant bacteria. Many U.S. cannabis advocates say it’s further evidence that legal barriers to cannabis research need to come down — and fast.
Amid all the utopian sensationalism about the supposedly salubrious properties of the cannabinoid CBD, some are...
U.S, February 12, 2020 (CANNABISTECH) Solving bioavailability issues with cannabinoids, nanoemulsion technology and ultrasonic techniques increase product effectiveness.
Cannabis has always had an issue with bioavailability. Whether smoked, eaten, or applied, each method of delivery loses a significant percentage of medicinal or...